Delivery Order SPE2DB20D2104-SPE2DB23FS47R
Award Date 3/6/23
Potential Completion Date 3/27/23
Potential Value $4.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,997.42 Firm Fixed Price Delivery Order covers the supply of INQOVI 35 MG-100 MG TABLET for an ultimate completion date of January 23, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,119.36 delivery order contract is for the supply of INQOVI 35 MG-100 MG TABLET medical products. The contract has an ultimate completion date of February 19, 2025 and is a firm fixed-price contract. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,830.47 firm-fixed-price delivery order is for the supply of the medication INQOVI 35 MG-100 MG TABLET, with a performance period through November 6, 2024. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
- This federal contract award, valued at $4,830.47, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of INQOVI 35 MG-100 MG tablets, a medical product used in various therapeutic areas. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
- This federal contract award, valued at $10,238.74, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of INQOVI 35 MG-100 MG TABLET, a pharmaceutical product, and has a completion date of March 6, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. In addition to this specific contract,...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,740.78, is for the delivery of INQOVI 35 MG-100 MG tablets. It is a Firm Fixed Price delivery order with a completion date of November 7, 2023. The contract is not designated as a set-aside and represents open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $5,119.36 and is a Firm Fixed Price Delivery Order that runs through February 26, 2025. The contract is not designated as a set-aside. The contract covers the delivery of the pharmaceutical product INQOVI 35 MG-100 MG TABLET, which is likely used in federal healthcare programs, potentially...
- This federal contract award, valued at $5,119.36, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order (DO) for the medical product "INQOVI 35 MG-100 MG TABLET UU 5S" and has a completion date of March 25, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
- This federal contract award (SPE2DX15D3201|SPE2DX24F2N5G) was made by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $4,740.78 firm fixed-price delivery order is for the pharmaceutical product INQOVI 35 MG-100 MG TABLET. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, which provides a comprehensive range of pharmaceutical...
- This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of INQOVI 35 MG-100 MG TABLET, a pharmaceutical product, with a ceiling value of $4,740.78 and a period of performance through December 6, 2023. The contract is a firm fixed-price arrangement and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery...